Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 612

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis

Bjelakovic, Goran, Nikolova, Dimitrinka, Simonetti, Rosa G, Gluud, Christian·2004·The Lancet

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(04)17138-9

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 54

  1. Ames, 1995, The causes and prevention of cancer, Proc Natl Acad Sci USA, 92, 5258, 10.1073/pnas.92.12.5258 · DOI · Paper page
  2. Halliwell, 2000, The gastrointestinal tract: a major site of antioxidant action?, Free Radic Res, 33, 819, 10.1080/10715760000301341 · DOI · Paper page
  3. Poppel, 1997, Vitamins and cancer, Cancer Lett, 114, 195, 10.1016/S0304-3835(97)04662-4 · DOI
  4. Diplock, 1994, Antioxidants and disease prevention, Mol Aspects Med, 15, 293, 10.1016/0098-2997(94)90005-1 · DOI · Paper page
  5. Sporn, 2000, Chemoprevention of cancer, Carcinogenesis, 21, 525, 10.1093/carcin/21.3.525 · DOI · Paper page
  6. Salganik, 2001, The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population, J Am Coll Nutr, 20, 464S, 10.1080/07315724.2001.10719185 · DOI · Paper page
  7. Thomson, 1998, Oxidative stress and antioxidants in intestinal disease, Dig Dis, 16, 152, 10.1159/000016859 · DOI
  8. Tamimi, 2002, Prospect for chemoprevention of cancer, J Intern Med, 251, 286, 10.1046/j.1365-2796.2002.00969.x · DOI
  9. Pritchard, 1996, Apoptosis and gastrointestinal pharmacology, Pharmacol Ther, 72, 149, 10.1016/S0163-7258(96)00102-7 · DOI
  10. Sihvo, 2002, Oxidative stress has a role in malignant transformation in Barrett's oesophagus, Int J Cancer, 102, 551, 10.1002/ijc.10755 · DOI
  11. Boyle, 1985, Descriptive epidemiology of colorectal cancer, Int J Cancer, 36, 9, 10.1002/ijc.2910360103 · DOI
  12. Weisburger, 1991, Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids, Am J Clin Nutr, 53, S226, 10.1093/ajcn/53.1.226S · DOI
  13. Poppel, 1996, Epidemiological evidence for beta-carotene in prevention of cancer and cardiovascular disease, Eur J Clin Nutr, 50, S57
  14. Lee, 2003, Beneficial and adverse effects of chemopreventive agents, Mutat Res, 523–24, 265, 10.1016/S0027-5107(02)00342-1 · DOI
  15. Paolini, 2003, Beta-carotene: a cancer chemopreventive agent or a co-carcinogen?, Mutat Res, 543, 195, 10.1016/S1383-5742(03)00002-4 · DOI
  16. Bjelakovic, 2003, Antioxidants for preventing gastrointestinal cancers (protocol for a Cochrane Review)
  17. Kjaergard, 2001, Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses, Ann Intern Med, 135, 982, 10.7326/0003-4819-135-11-200112040-00010 · DOI · Paper page
  18. DeMets, 1987, Methods for combining randomized clinical trials: strengths and limitations, Stat Med, 66, 341, 10.1002/sim.4780060325 · DOI · Paper page
  19. Altman, 2003, Interaction revisited: the difference between two estimates, BMJ, 326, 219, 10.1136/bmj.326.7382.219 · DOI · Paper page
  20. Munoz, 1985, No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus: randomised double-blind intervention study in high-risk population of China, Lancet, 326, 111, 10.1016/S0140-6736(85)90223-5 · DOI
  21. Yu, 1991, A preliminary report on the intervention trials of primary liver cancer in high-risk populations with nutritional supplementation of selenium in China, Biol Trace Elem Res, 29, 289, 10.1007/BF03032685 · DOI
  22. Blot, 1993, Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population, J Natl Cancer Inst, 85, 1483, 10.1093/jnci/85.18.1483 · DOI · Paper page
  23. Li, 1993, Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia, J Natl Cancer Inst, 85, 1492, 10.1093/jnci/85.18.1492 · DOI · Paper page
  24. Clark, 1996, Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial, JAMA, 276, 1957, 10.1001/jama.1996.03540240035027 · DOI · Paper page
  25. Hennekens, 1996, Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease, N Engl J Med, 334, 1145, 10.1056/NEJM199605023341801 · DOI · Paper page
  26. Yu, 1997, Protective role of selenium against hepatitis B virus and primary liver cancer in Qidong, Biol Trace Elem Res, 56, 117, 10.1007/BF02778987 · DOI · Paper page
  27. Lee, 1999, Randomised beta-carotene supplementation and incidence of cancer and cardiovascular disease in women: the Women's Health Study, J Natl Cancer Inst, 91, 2102, 10.1093/jnci/91.24.2102 · DOI · Paper page
  28. Li, 2000, The prevention of primary liver cancer by selenium in high-risk populations, Zhonghua Yu Fang Yi Xue Za Zhi, 34, 336
  29. Correa, 2000, Chemoprevention of gastric dysplasia: randomized trial of antioxidant supplements and anti- Helicobacter pylori therapy, J Natl Cancer Inst, 92, 1881, 10.1093/jnci/92.23.1881 · DOI · Paper page
  30. Zhu, 2002, The interventional effect of folic acid on the development of gastric and other gastrointestinal cancers—clinical trial and follow-up for seven years, Chin J Gastroenterol, 7, 73
  31. Caraballoso, 2004, Drugs for preventing lung cancer in healthy people (Cochrane Review)
  32. van den Broek, 2003, Vitamin A supplementation during pregnancy (Cochrane Review)
  33. Darlow, 2003, Vitamin A supplementation for preventing morbidity and mortality in very low birthweight infants (Cochrane Review)
  34. Glasziou, 1993, Vitamin A supplementation in infectious diseases: a meta-analysis, BMJ, 306, 366, 10.1136/bmj.306.6874.366 · DOI · Paper page
  35. Hercberg, 1999, “The SU.VI.MAX Study”: a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers, Food Chem Toxicol, 37, 925, 10.1016/S0278-6915(99)00078-2 · DOI
  36. Klein, 2003, SELECT: the selenium and vitamin E cancer prevention trial, Urol Oncol, 21, 59, 10.1016/S1078-1439(02)00301-0 · DOI
  37. McKeown-Eyssen, 1988, A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps, Cancer Res, 48, 4701
  38. Roncucci, 1993, Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the health-care district 16, Dis Colon Rectum, 36, 227, 10.1007/BF02053502 · DOI
  39. Greenberg, 1994, A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group, New Eng J Med, 331, 141, 10.1056/NEJM199407213310301 · DOI · Paper page
  40. MacLennan, 1995, Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. The Australian Polyp Prevention Project. J, Natl Cancer Inst, 87, 1760, 10.1093/jnci/87.23.1760 · DOI · Paper page
  41. Ponz de Leon, 1997, Chemoprevention of colorectal tumors: role of lactulose and of other agents, Scand J Gastroenterol, 222, 72, 10.1080/00365521.1997.11720724 · DOI
  42. Hofstad, 1998, Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants, Digestion, 59, 148, 10.1159/000007480 · DOI
  43. Malila, 1999, The effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged male smokers, Cancer Epidemiol Biomarkers Prev, 8, 489
  44. Janne, 2000, Chemoprevention of colorectal cancer, N Engl J Med, 342, 1960, 10.1056/NEJM200006293422606 · DOI · Paper page
  45. Shikany, 2003, Antioxidant supplement use in Women's Health Initiative, Prev Med, 36, 379, 10.1016/S0091-7435(02)00050-6 · DOI
  46. Karakaya, 1999, Antimutagenic activities of some foods, J Agricultur Food Chem, 79, 237, 10.1002/(SICI)1097-0010(199902)79:2<237::AID-JSFA178>3.0.CO;2-K · DOI
  47. Greenwald, 2001, Diet and cancer prevention, Eur J Cancer, 37, 948, 10.1016/S0959-8049(01)00070-3 · DOI · Paper page
  48. Kaur, 2001, Antioxidants in fruits and vegetables—the millennium's health, Int J Food Science Technol, 36, 703, 10.1046/j.1365-2621.2001.00513.x · DOI · Paper page
  49. Camire, 1999, Dietary supplements: nutritional and legal considerations, Food Technol, 53, 87
  50. Halliwell, 1997, Antioxidants and human disease: a general introduction, Nutr Rev, 55, S44, 10.1111/j.1753-4887.1997.tb06100.x · DOI · Paper page
  51. Michels, 2000, Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers, J Natl Cancer Inst, 92, 1740, 10.1093/jnci/92.21.1740 · DOI · Paper page
  52. Botterweck, 1998, A prospective cohort study on vegetable and fruit consumption and stomach cancer risk in the Netherlands, Am J Epidemiol, 148, 842, 10.1093/oxfordjournals.aje.a009709 · DOI
  53. Schatzkin, 2000, Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group, N Engl J Med, 342, 1149, 10.1056/NEJM200004203421601 · DOI · Paper page
  54. Omenn, 1998, Chemoprevention of lung cancer: the rise and demise of beta-carotene, Annu Rev Public Health, 19, 73, 10.1146/annurev.publhealth.19.1.73 · DOI

Cited by

See all 612

Metadata

Authors
Bjelakovic, G., Nikolova, D., Simonetti, R. G., & Gluud, C.
Venue
The Lancet
Publisher
Elsevier BV
Published
2004-10
Volume
364
Issue
9441
Pages
1219-1228
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2002956860
Cited by
612
References
11
FWCI
4.46
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.